cisplatin,atezolizumab
roche
['atezo', 'cisplatin', 'imvigor130', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'bladder']
final overall survival (os) analysis of atezolizumab monotherapy vs chemotherapy imvigor130 dr. aristotelis bamias -better tolerability, no os benefit! #gu23 #medtwitter #bladdercancer 
On the road!
Pursuing to improve global health through sharing knowledge, cancer prevention, and care.  
Medical oncologist @AnkaraUni